{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:31:25Z","timestamp":1790767885951,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T00:00:00Z","timestamp":1513296000000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ymgme.2017.10.006","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T06:01:25Z","timestamp":1508133685000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"S","title":["Epilepsy in mucopolysaccharidosis disorders"],"prefix":"10.1016","volume":"122","author":[{"given":"Maurizio","family":"Scarpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-6098","authenticated-orcid":false,"given":"Charles Marques","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Amartino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2017.10.006_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2017.10.006_bb0010","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/PRM-2010-0102","article-title":"Orthopedic management of mucopolysaccharide disease","volume":"3","author":"White","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3174\/ajnr.A2832","article-title":"Brain and spinal MR imaging findings in mucopolysaccharidoses: a review","volume":"34","author":"Zafeiriou","year":"2013","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/PRM-2010-0115","article-title":"Radiologic and neuroradiologic findings in the mucopolysaccharidoses","volume":"3","author":"Lachman","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/PRM-2010-0103","article-title":"Clinical assessment and treatment of carpal tunnel syndrome in the mucopolysaccharidoses","volume":"3","author":"White","year":"2010","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo4030655","article-title":"Establishment of glycosaminoglycan assays for mucopolysaccharidoses","volume":"4","author":"Tomatsu","year":"2014","journal-title":"Metabolites"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.mehy.2010.07.044","article-title":"Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?","volume":"75","author":"W\u0119grzyn","year":"2010","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0045","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3565","article-title":"Signals from the lysosome: a control centre for cellular clearance and energy metabolism","volume":"14","author":"Settembre","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/brain\/awu355","article-title":"Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model","volume":"138","author":"Martins","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0055","doi-asserted-by":"crossref","first-page":"e1049793","DOI":"10.1080\/21675511.2015.1049793","article-title":"Crosstalk between 2 organelles: Lysosomal storage of heparan sulfate causes mitochondrial defects and neuronal death in mucopolysaccharidosis III type C","volume":"3","author":"Pshezhetsky","year":"2015","journal-title":"Rare Dis."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0060","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1038\/cddis.2013.430","article-title":"Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved","volume":"4","author":"Fusar Poli","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/adc.73.1.77","article-title":"Behaviour in mucopolysaccharide disorders","volume":"73","author":"Bax","year":"1995","journal-title":"Arch. Dis. Child."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2017.10.006_bb0070","first-page":"133","article-title":"Mucopolysaccharidosis III (Sanfilippo syndrome) - disease presentation and experimental therapies","volume":"12","author":"Gilkes","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0075","doi-asserted-by":"crossref","first-page":"e1258","DOI":"10.1542\/peds.2010-1274","article-title":"Natural progression of neurological disease in mucopolysaccharidosis type II","volume":"127","author":"Holt","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2015.06.002","article-title":"Neurocognition across the spectrum of mucopolysaccharidosis type I: age, severity, and treatment","volume":"116","author":"Shapiro","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00710053","article-title":"Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation","volume":"18","author":"Shapiro","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5 Suppl","key":"10.1016\/j.ymgme.2017.10.006_bb0090","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jpeds.2004.01.052","article-title":"The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations","volume":"144","author":"Muenzer","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-5876(90)90215-D","article-title":"Degeneration of speech, language, and hearing in a patient with mucopolysaccharidosis VII","volume":"19","author":"Wallace","year":"1990","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2017.10.006_bb0100","first-page":"89","article-title":"An autopsy case of Sanfilippo A syndrome with severe cerebral cortical involvement","volume":"20","author":"Watanabe","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1684\/j.1950-6945.2000.tb00442.x","article-title":"Prognosis in nonconvulsive status epilepticus","volume":"2","author":"Kaplan","year":"2000","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0110","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0115","doi-asserted-by":"crossref","first-page":"ITC17","DOI":"10.7326\/AITC201602020","article-title":"Epilepsy","volume":"164","author":"Krishnamurthy","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0120","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1469-8749.1983.tb13794.x","article-title":"The natural history of the severe form of Hunter's syndrome: a study based on 52 cases","volume":"25","author":"Young","year":"1983","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"H\u00e9ron","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mcn.2009.01.001","article-title":"Enhanced degradation of synaptophysin by the proteasome in mucopolysaccharidosis type IIIB","volume":"41","author":"Vitry","year":"2009","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0135","doi-asserted-by":"crossref","first-page":"e35787","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"Wilkinson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0140","series-title":"Lysosomal Storage Diseases: Early Diagnosis and New Treatments","first-page":"73","article-title":"Epilepsy in mucopolysaccharidosis: clinical features and outcome","author":"Grioni","year":"2010"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0145","first-page":"S56","article-title":"Particular features of neurological symptoms with children suffering from MPS syndrome type II","volume":"108","author":"Kuzenkova","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2017.10.006_bb0150","first-page":"S192","article-title":"Epileptic seizures profile in patients with mucopolysaccharidosis (MPS) types I, II and VI","volume":"39","author":"Mendes","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1590\/S1676-26492010000400008","article-title":"Aspectos eletrencefalogr\u00e1ficos em crian\u00e7as com mucopolissacaridose","volume":"16","author":"Albuquerque","year":"2010","journal-title":"J. Epilepsy Clin. Neurophysiol."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0160","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/archneur.1978.00500360062013","article-title":"Neuroanatomical and electroencephalographic correlations in Sanfilippo syndrome, type A","volume":"35","author":"Kriel","year":"1978","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0165","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1469-8749.2012.04228.x","article-title":"Non-convulsive status epilepticus of frontal origin in mucopolysaccharidosis type II successfully treated with ethosuximide","volume":"54","author":"Bonanni","year":"2012","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0170","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2012.07.016","article-title":"An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT)","volume":"107","author":"Shapiro","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type II","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/jmg.19.6.408","article-title":"A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms","volume":"19","author":"Young","year":"1982","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0185","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10072-016-2788-2","article-title":"Association between brain structural anomalies, electroencephalogram and history of seizures in mucopolysaccharidosis type II (Hunter syndrome)","volume":"38","author":"Jim\u00e9nez-Arredondo","year":"2017","journal-title":"Neurol. Sci."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2017.10.006_bb0190","doi-asserted-by":"crossref","first-page":"s67","DOI":"10.1007\/s10545-009-9023-8","article-title":"Hunter syndrome in an 11-year old girl on enzyme replacement therapy with idursulfase: brain magnetic resonance imaging features and evolution","volume":"33","author":"Manara","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/adc.69.3.403","article-title":"Management of mucopolysaccharidosis type III","volume":"69","author":"Cleary","year":"1993","journal-title":"Arch. Dis. Child."},{"issue":"Pt 3","key":"10.1016\/j.ymgme.2017.10.006_bb0200","first-page":"185","article-title":"Developmental and degenerative patterns associated with cognitive, behavioural and motor difficulties in the Sanfilippo syndrome: an epidemiological study","volume":"27","author":"Nidiffer","year":"1983","journal-title":"J. Ment. Defic. Res."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1750-1172-8-189","article-title":"Natural history of Sanfilippo syndrome in Spain","volume":"8","author":"Delgadillo","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0210","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.22092","article-title":"Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations","volume":"68","author":"Valstar","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0215","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.braindev.2013.12.002","article-title":"Nocturnal frontal lobe epilepsy in mucopolysaccharidosis","volume":"36","author":"Bonanni","year":"2014","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ajmg.c.30142","article-title":"Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems?","volume":"145C","author":"Moog","year":"2007","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0225","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10545-010-9199-y","article-title":"Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype","volume":"33","author":"Valstar","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0230","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2007.09.011","article-title":"Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in the Netherlands","volume":"93","author":"Ruijter","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0235","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/hmg\/6.3.479","article-title":"Molecular and phenotypic variation in patients with severe Hunter syndrome","volume":"6","author":"Timms","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0240","series-title":"Essentials of Medical Pharmacology","first-page":"411","author":"Tripathi","year":"2013"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-444-52898-8.00005-7","article-title":"Classification of epilepsies and seizures: historical perspective and future directions","volume":"107","author":"Berg","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0250","author":"The International League Against Epilepsy"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0255","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpeds.2011.03.019","article-title":"Early clinical markers of central nervous system involvement in mucopolysaccharidosis type II","volume":"159","author":"Holt","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0260","first-page":"52","article-title":"Cerebral choline acetyltransferase and acetylcholinesterase activities in a Sanfilippo syndrome, in a myoclonic epilepsy and in various zones of the human newborn brain","volume":"33","author":"Federico","year":"1978","journal-title":"Acta Neurol. (Napoli)"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0265","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2007-973503","article-title":"Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome)","volume":"30","author":"Barone","year":"1999","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2017.10.006_bb0270","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00005072-199710000-00010","article-title":"Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics","volume":"56","author":"Jones","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2017.10.006_bb0275","first-page":"S186","article-title":"EEG features in patients with mucopolysaccharidoses III at different disease stages","volume":"39","author":"Barone","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0280","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/155005940303400108","article-title":"Sleep disorders in Sanfilippo syndrome: a polygraphic study","volume":"34","author":"Mariotti","year":"2003","journal-title":"Clin. Electroencephalogr."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0285","doi-asserted-by":"crossref","first-page":"90","DOI":"10.17925\/ENR.2015.10.01.90","article-title":"Hunter syndrome (mucopolysaccharidosis II) - the signs and symptoms a neurologist needs to know","volume":"10","author":"Amartino","year":"2015","journal-title":"Eur. Neurol. Rev."},{"key":"10.1016\/j.ymgme.2017.10.006_bb0290","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2017.08.008","article-title":"Pathophysiology, evaluation and management of sleep disorders in the mucopolysaccharidoses","volume":"122","author":"Rapoport","year":"2017","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217305024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719217305024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T19:58:28Z","timestamp":1719518308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719217305024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":58,"alternative-id":["S1096719217305024"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.10.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy in mucopolysaccharidosis disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}